Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm-Reference-Cited by-同舟云学术

Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm

Published:2021-06 Issue: Volume:38 Page:101149
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Kim Hyelim,Lee Han Sol,Ahn June Hong,Hong Kyung Soo^ORCID,Jang Jong Geol,An Jiseon,Mun Yong-Hyeon,Yoo So-Yeol,Choi Yoon Jung,Yun Mi-Young,Song Gyu Yong,Joo Jinmyoung^ORCID,Na Dong Hee,Kim Hong Nam,Park Hee Ho,Lee Jae-Young^ORCID,Lee Wonhwa^ORCID

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference46 articles.

1. Evolution of the COVID-19 vaccine development landscape;Le;Nat. Rev. Drug Discov.,2020

2. COVID-19: immunopathology and its implications for therapy;Cao;Nat. Rev. Immunol.,2020

3. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients;Hadjadj;Science,2020

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry;Life Science Alliance;2024-02-22

2. SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP–SREBP signaling pathway;Tissue and Cell;2024-02

3. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies;Viruses;2024-01-31

4. Excess phosphate promotes SARS‑CoV‑2 N protein‑induced NLRP3 inflammasome activation via the SCAP‑SREBP2 signaling pathway;Molecular Medicine Reports;2024-01-25

5. Lipid compartments and lipid metabolism as therapeutic targets against coronavirus;Frontiers in Immunology;2023-12-01